$MSCI

Why MSCI Stock Is Plummeting Lower Today

MSCI shares fell about 10% to around $561.74 after the company reported Q2 results that missed Wall Street expectations, despite sales up 12% and adjusted EPS up 19%. MSCI also slightly raised 2026 expense guidance tied to integrating First Street. Investors are reacting to the earnings and guidance.

Original reporting
Published Jul 21, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why MSCI Stock Is Plummeting Lower Today — source image
Decision brief

The 30-second read

$MSCIBearishMed
01

Why it matters

The market reaction is attributed to the earnings miss and expense guidance increase, which may outweigh the growth in revenue and EPS in the near term.

02

Market read

Traders can reassess near-term expectations for MSCI’s margin trajectory and integration costs after the earnings miss and guidance update.

03

What to watch

AI indexing and analytics substitution risk is discussed, but the article provides no new evidence of customer churn or contract losses, which could limit how far the multiple compresses.

Relevance 8/10Novelty 6/10Timing: As of 3 p.m. ET Tuesday, after MSCI’s Q2 earnings and guidance reaction.

Background

MSCI reported Q2 results that grew sales and adjusted EPS but missed consensus, while integrating First Street and slightly raising 2026 expense guidance.

Company-level read

Ticker impact

$MSCIBearishMedium confidence
Context

MSCI shares fell about 10% after its Q2 results and adjusted EPS missed Wall Street expectations, per the article.

Expected impact

Near-term volatility likely remains elevated until investors digest the guidance and integration impact.

Evidence & confidence

The article cites a same-day earnings disappointment and guidance change, both of which can reset near-term expectations and valuation multiples.

Market effects

Could pressure other index, analytics, and data providers if investors broaden the read-across on AI disruption fears.

Primarily US-listed large-cap sentiment impact, with potential spillover to global data/benchmarking peers.

MSCI is a global benchmark provider, so any credibility or growth concern can affect broader capital-markets sentiment.

Counterpoint

The article argues the valuation is now more reasonable (29x FCF) and the results are “fine,” implying the selloff may be overdone.

Key entities

  • MSCI

    Global index and analytics provider whose Q2 earnings and 2026 expense guidance drove the stock’s sharp drop in the article.

  • First Street

    Climate-risk modeling firm MSCI is integrating, referenced as the reason for higher expense guidance.

Related articles

$MSCIMed

Transcript: MSCI Q2 2026 Earnings Conference Call

MSCI (NYSE:MSCI) reported Q2 2026 results on a conference call. The company said organic revenue growth was over 12%, adjusted EPS growth nearly 19%, and adjusted EBITDA growth 14%. It cited total run rate growth of 12%, ABF run rate growth of 25% to $948 million, and ETF-linked inflows of nearly $40 billion. MSCI repurchased $147 million of shares at about $558 average.

$SNDKMed

Stocks Gain as Chipmakers Rebound

Stocks rose as chipmakers and AI-infrastructure shares rebounded. The iShares Semiconductor ETF (SOXX) gained over 3%, while Sandisk (SNDK), Micron (MU), Western Digital (WDC), and others rose. Bitcoin hit a 1-month high, lifting Coinbase (COIN) and Circle (CRCL). Hasbro (HAS) reported Q2 net revenue $1.14B and raised guidance; 3M (MMM) beat EPS and lifted outlook.

$MSCIMed

MSCI-Linked ETF AUM Tops $2.8 Trillion, but Investors Still Sold the Stock - MSCI (NYSE:MSCI)

MSCI reported operating revenue of $867 million, up 12.2% year over year, slightly above expectations of $866.4 million, driven by higher recurring subscription and asset-based fees. MSCI-linked ETF AUM rose above $2.8 trillion on nearly $40 billion in Q2 inflows. Despite record inflows, MSCI shares fell about 10% Tuesday to $561.74. The company raised 2026 cash flow and expense outlooks.

$MSCIMed

MSCI Q2 Earnings Call Highlights

MSCI reported Q2 results on its earnings call. CFO Andy Wiechmann said the asset-based fee run rate neared $950 million and ETF AUM linked to MSCI indexes rose to over $2.8 trillion. Management cited 17% index run rate growth, 41% recurring net new sales growth, and retention above 97%, plus Private Assets growth and AI product adoption. Sustainability and climate sales faced cancellations; guidance turned roughly zero to slightly negative.